The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BeOne Medicines Ltd ADR shares valued at $7,044,591 were sold by OYLER JOHN on Jul 09 ’25. At $253.38 per share, OYLER JOHN sold 27,802 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, JOHN V OYLER purchased 27,802 shares, netting a total of over 6,796,755 in proceeds.
Before that, PAN-OYLER FOUNDATION had added 1,661 shares to its account. In a trade valued at $400,284, the Director bought BeOne Medicines Ltd ADR shares for $240.99 each.
As published in their initiating research note from RBC Capital Mkts on April 07, 2025, BeOne Medicines Ltd ADR [ONC] has been an Outperform and the price target has been revised to $312. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early March. Earlier on September 18, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for ONC stock.
Analyzing ONC Stock Performance
On last trading session,, BeOne Medicines Ltd ADR [NASDAQ: ONC] rose 4.01% to $290.35. The stock’s lowest price that day was $287.33, but it reached a high of $298.0 in the same session. During the last five days, there has been a surge of approximately 14.59%. Over the course of the year, BeOne Medicines Ltd ADR shares have jumped approximately 96.50%.
Support And Resistance Levels for BeOne Medicines Ltd ADR (ONC)
RSI (Relative Strength Index) is 70.51 on the 14-day chart, showing overbought technical sentiment.
Is BeOne Medicines Ltd ADR subject to short interest?
Stocks of BeOne Medicines Ltd ADR saw a sharp steep in short interest on 2025-06-13 dropping by -0.11 million shares to 1.92 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 2.03 million shares. A decline of -5.77% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.91 of the overall float, the days-to-cover ratio (short ratio) decline to 5.91.
Which companies own the most shares of BeOne Medicines Ltd ADR (ONC)?
In terms of BeOne Medicines Ltd ADR share price expectations, FactSet research, analysts set an average price target of 303.5 in the next 12 months, up nearly 8.72% from the previous closing price of $279.16. Analysts anticipate BeOne Medicines Ltd ADR stock to reach 348 by 2025, with the lowest price target being 259. On February 06, 2024, JP Morgan assigned a price target of “an Overweight” to the stock and resumed coverage with a $185.
